Stéphane Pouderoux

Programmed Cell Death Ligand 1-Expressing Circulating Tumor Cells: A New Prognostic Biomarker in Non-Small Cell Lung Cancer

Léa Sinoquet, William Jacot, Ludovic Gauthier et al. · Clinical Chemistry · 2021 · 86 citations · Full text

Medicine, Cancer Biology, Oncology +17

Clinical Correlations of Programmed Cell Death Ligand 1 Status in Liquid and Standard Biopsies in Breast Cancer

William Jacot, Martine Mazel, Caroline Mollévi et al. · Clinical Chemistry · 2020 · 49 citations · Full text

Medicine, Oncology, Breast Oncology +16

Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy

William Jacot, Stéphane Pouderoux, Simon Thézenas et al. · Breast Cancer Research and Treatment · 2012 · 45 citations

Medicine, Oncology, Pharmacology +16

Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology

Gaia Griguolo, Stéphane Pouderoux, Maria Vittoria Dieci et al. · The Oncologist · 2018 · 45 citations · Full text

Medicine, Cancer Biology, Oncology +17

Circulating tumour cells and PD-L1-positive small extracellular vesicles: the liquid biopsy combination for prognostic information in patients with metastatic non-small cell lung cancer

Zahra Eslami‐S, Luis Enrique Cortés‐Hernández, Léa Sinoquet et al. · British Journal of Cancer · 2023 · 42 citations · Full text

Medicine, Clinical Sciences, Oncology +17